In addition to it's clinical advanatges, QCT offers a signficant cost-effectiveness advantage, particularly in comparison to DXA. QCT PRO gives you a realistic opportunity to profit from your investment, quite possibly significantly. With a system that utilizes existing equipment and staff, a price between $14,500 and $27,000 with virtually no additional or recurring costs, and with reimbursements in the $140 range, it takes only a small number of patients to become profitable.

In stark contrast, DXA requires a significant capital investment, requires additional existing floor space, often room preparation, staffing, service contracts and other recurring cost, DXA systems require signficantly more patient to cover basic operating costs. If you closely examine the numbers we think you will find that QCT PRO is about 4 times more cost-effective than DXA. In other words, the break even patient volume is about one-fourth, or the profit potential is about 4 times greater.

Here are 4 links that can help you to analyze the economics of QCT for your site:

A free program that lets you input patient demographics and operating costs and calculates profit and loss. Can compare two systems.

Sample QCT vs. DXA Cost Analysis

A sample report from BMD FA software that compares QCT to DXA.

HCFA Guidelines

The latest guidelines from HCFA

Reimbursement Codes